AZN DEADLINE: ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important February 21 Deadline in Securities Class Action First Filed by the Firm - AZN — Neutral
AZN Accesswire — February 17, 2025NEW YORK, NY / ACCESS Newswire / February 17, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of AstraZeneca PLC (NASDAQ:AZN) between February 23, 2022 and December 17, 2024, both dates inclusive (the "Class Period"), of the February 21, 2025 lead plaintiff deadline in the securities class action first filed by the Firm. SO WHAT: If you purchased AstraZeneca securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
Shareholders of TELUS International (Cda) Inc. Should Contact Levi & Korsinsky Before March 31, 2025 to Discuss Your Rights - TIXT — Neutral
TIXT Accesswire — February 17, 2025NEW YORK, NY / ACCESS Newswire / February 17, 2025 / If you suffered a loss on your TELUS International (Cda) Inc. (NYSE:TIXT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/telus-international-lawsuit-submission-form?prid=130063&wire=1 or contact Joseph E. Levi, Esq.
Investors in GSK plc Should Contact Levi & Korsinsky Before April 7, 2025 to Discuss Your Rights - GSK — Neutral
GSK Accesswire — February 17, 2025NEW YORK, NY / ACCESS Newswire / February 17, 2025 / If you suffered a loss on your GSK plc (NYSE:GSK) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/gsk-lawsuit-submission-form?prid=130062&wire=1 or contact Joseph E. Levi, Esq.
Novo Nordisk (NVO) Faces Securities Class Action After Weight Loss Therapy Trial Data Disappoints, Analyst Questions Trial's Design – Hagens Berman — Neutral
NVO GlobeNewsWire — February 17, 2025SAN FRANCISCO, Feb. 17, 2025 (GLOBE NEWSWIRE) -- Novo Nordisk A/S (NYSE: NVO) is facing a class-action lawsuit from investors who allege the pharmaceutical giant misled them about the prospects of its experimental obesity drug, CagriSema.
Vimeo to Report Q4 Earnings: What's in the Offing for the Stock? — Neutral
VMEO Zacks Investment Research — February 17, 2025VMEO's top line is expected to have decreased on the back of declining revenues from Self-Serve and Add-Ons in the fourth quarter of 2024.
Wells Fargo's 2018 Compliance Consent Order by OCC Terminated — Neutral
WFC Zacks Investment Research — February 17, 2025WFC's 2018 consent order imposed on the bank in April 2018 is terminated. This marks the 10th consent order, which has been closed by regulators since 2019.
FMC Corporation (FMC) Accused of Misleading Investors About Sales and Inventory – Hagens Berman — Neutral
FMC GlobeNewsWire — February 17, 2025SAN FRANCISCO, Feb. 17, 2025 (GLOBE NEWSWIRE) -- FMC Corporation (NYSE: FMC), a global agricultural sciences company, is facing a class action lawsuit alleging that it misled investors about its business prospects, leading to a significant drop in the company's stock price.
APLT DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Applied Therapeutics, Inc. Investors to Secure Counsel Before Important February 18 Deadline in Securities Class Action - APLT — Neutral
APLT GlobeNewsWire — February 17, 2025NEW YORK, Feb. 17, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Applied Therapeutics, Inc. (NASDAQ: APLT) between January 3, 2024 and December 2, 2024, both dates inclusive (the “Class Period”), of the important February 18, 2025 lead plaintiff deadline.
Why First Business Financial Services (FBIZ) is a Great Dividend Stock Right Now — Positive
FBIZ Zacks Investment Research — February 17, 2025Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does First Business Financial Services (FBIZ) have what it takes?
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Shell (SHEL) have what it takes?
Why Atmos Energy (ATO) is a Great Dividend Stock Right Now — Positive
ATO Zacks Investment Research — February 17, 2025Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Atmos Energy (ATO) have what it takes?
Are You Looking for a High-Growth Dividend Stock? — Positive
BSRR Zacks Investment Research — February 17, 2025Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Sierra Bancorp (BSRR) have what it takes?
Why Hanmi Financial (HAFC) is a Great Dividend Stock Right Now — Positive
HAFC Zacks Investment Research — February 17, 2025Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Hanmi Financial (HAFC) have what it takes?
Why Northrim BanCorp (NRIM) is a Great Dividend Stock Right Now — Positive
NRIM Zacks Investment Research — February 17, 2025Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Northrim BanCorp (NRIM) have what it takes?
Why Arrow Financial (AROW) is a Great Dividend Stock Right Now — Positive
AROW Zacks Investment Research — February 17, 2025Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Arrow Financial (AROW) have what it takes?
Are You Looking for a High-Growth Dividend Stock? — Positive
GABC Zacks Investment Research — February 17, 2025Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does German American Bancorp (GABC) have what it takes?
First Merchants (FRME) Could Be a Great Choice — Positive
FRME Zacks Investment Research — February 17, 2025Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does First Merchants (FRME) have what it takes?
Prosperity Bancshares (PB) Could Be a Great Choice — Positive
PB Zacks Investment Research — February 17, 2025Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Prosperity Bancshares (PB) have what it takes?
SB Financial Group, Inc. (SBFG) is a Top Dividend Stock Right Now: Should You Buy? — Positive
SBFG Zacks Investment Research — February 17, 2025Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does SB Financial Group, Inc. (SBFG) have what it takes?
Why Home Bancorp (HBCP) is a Top Dividend Stock for Your Portfolio — Positive
HBCP Zacks Investment Research — February 17, 2025Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Home Bancorp (HBCP) have what it takes?
